Document is current
Any future updates will be listed below
-
Authors
Han, Shasha https://orcid.org/0000-0001-7388-8125
Cai, Jun https://orcid.org/0000-0001-9495-1226
Yang, Juan https://orcid.org/0000-0001-5028-2227
Zhang, Juanjuan
Wu, Qianhui
Zheng, Wen
Shi, Huilin
Ajelli, Marco https://orcid.org/0000-0003-1753-4749
Zhou, Xiao-Hua https://orcid.org/0000-0001-7935-1222
Yu, Hongjie https://orcid.org/0000-0002-6335-5648
- License Information
-
More Information
Article History
Received: 23 February 2021
Accepted: 12 July 2021
First Online: 3 August 2021
Competing interests
: M.A. has received research funding from Seqirus. H.Y. has received research funding from Sanofi Pasteur, GlaxoSmithKline, Yichang HEC Changjiang Pharmaceutical Company, and Shanghai Roche Pharmaceutical Company. None of those research funding is related to COVID-19. All other authors report no competing interests.
